Detalles de la búsqueda
1.
Antitumor activity of motesanib alone and in combination with cisplatin or docetaxel in multiple human non-small-cell lung cancer xenograft models.
Mol Cancer
; 11: 70, 2012 Sep 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-22992329
2.
Tumor penetration and epidermal growth factor receptor saturation by panitumumab correlate with antitumor activity in a preclinical model of human cancer.
Mol Cancer
; 11: 47, 2012 Jul 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-22830443
3.
Effects of palifermin on antitumor activity of chemotherapeutic and biological agents in human head and neck and colorectal carcinoma xenograft models.
Mol Cancer Res
; 6(8): 1337-46, 2008 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-18708365
4.
Evaluation of a series of naphthamides as potent, orally active vascular endothelial growth factor receptor-2 tyrosine kinase inhibitors.
J Med Chem
; 51(6): 1668-80, 2008 Mar 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-18324759
5.
Naphthamides as novel and potent vascular endothelial growth factor receptor tyrosine kinase inhibitors: design, synthesis, and evaluation.
J Med Chem
; 51(6): 1649-67, 2008 Mar 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-18324761
6.
The inhibition of RANKL causes greater suppression of bone resorption and hypercalcemia compared with bisphosphonates in two models of humoral hypercalcemia of malignancy.
Endocrinology
; 146(8): 3235-43, 2005 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-15845617
7.
Cinacalcet attenuates hypercalcemia observed in mice bearing either Rice H-500 Leydig cell or C26-DCT colon tumors.
Eur J Pharmacol
; 712(1-3): 8-15, 2013 Jul 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-23623934
8.
AMG 706, an oral, multikinase inhibitor that selectively targets vascular endothelial growth factor, platelet-derived growth factor, and kit receptors, potently inhibits angiogenesis and induces regression in tumor xenografts.
Cancer Res
; 66(17): 8715-21, 2006 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-16951187
Resultados
1 -
8
de 8
1
Próxima >
>>